Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Enterprise Value (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Enterprise Value for 5 consecutive years, with -$2.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value rose 51.11% year-over-year to -$2.3 billion, compared with a TTM value of -$2.3 billion through Dec 2025, up 51.11%, and an annual FY2025 reading of -$4.4 billion, up 27.06% over the prior year.
  • Enterprise Value was -$2.3 billion for Q4 2025 at Roivant Sciences, up from -$3.9 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$976.6 million in Q2 2023 and bottomed at -$6.2 billion in Q4 2023.
  • Average Enterprise Value over 5 years is -$2.8 billion, with a median of -$2.1 billion recorded in 2021.
  • The sharpest move saw Enterprise Value plummeted 436.56% in 2024, then skyrocketed 51.11% in 2025.
  • Year by year, Enterprise Value stood at -$2.2 billion in 2021, then grew by 29.95% to -$1.5 billion in 2022, then crashed by 304.34% to -$6.2 billion in 2023, then rose by 22.28% to -$4.8 billion in 2024, then surged by 51.11% to -$2.3 billion in 2025.
  • Business Quant data shows Enterprise Value for ROIV at -$2.3 billion in Q4 2025, -$3.9 billion in Q3 2025, and -$2.9 billion in Q2 2025.